Clinical Trials Logo

Clinical Trial Summary

The goal of the ALOFT study is to understand the health of women in the 12 years following a uterine fibroid (UF) treatment. ALOFT is a multi-center, prospective, observational cohort study of approximately 700 women who have undergone uterine-sparing treatment procedures for UF and previously participated in the longitudinal studies COMPARE-UF (NCT02260752) or ULTRA (NCT02100904). The primary uterine sparing treatment procedures undergone by study participants are myomectomy, endometrial ablation (EA), uterine artery embolization (UAE) and laparoscopic radiofrequency ablation (RFA). A smaller number of women may be studied who underwent focused ultrasound, intrauterine device (IUD), and medical management. Two follow-up study contacts with COMPARE-UF and ULTRA participants will occur to assess changes in UF symptoms and treatment failure which is defined as the need for another UF treatment procedure. Questionnaires will be used to collect data on patient-reported characteristics and outcomes and quality of life. The study's analyses will focus on comparisons of primary and secondary outcomes among women.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06430320
Study type Observational
Source Henry Ford Health System
Contact
Status Enrolling by invitation
Phase
Start date May 20, 2024
Completion date August 2027

See also
  Status Clinical Trial Phase
Terminated NCT04073485 - Microwave Ablation for Uterine Fibroids N/A
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Recruiting NCT01239641 - High Intensity Focused Ultrasound Ablation Virus Myomectomy to Treat Uterine Fibroids Phase 4
Recruiting NCT04748978 - OPPIuM Technique and Myolysis With Diode Laser Dwls N/A
Not yet recruiting NCT04191603 - TWO DÄ°FFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY N/A
Terminated NCT04132349 - Ulipristal Acetate in Symptomatic Uterine Fibroid Phase 4
Completed NCT03412890 - LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Phase 3
Completed NCT03021720 - Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial N/A
Recruiting NCT04209036 - Can 3D Laparoscopy Improve Surgical Performances in Surgeons in Training?
Completed NCT05086770 - Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere N/A
Recruiting NCT05416424 - Life Study: Lifestyle Intervention in Fibroid Elimination N/A
Not yet recruiting NCT05695690 - Role of US in Uterine Fibroids in Comparison With MRI Using FIGO Classification
Completed NCT04832906 - UA Versus UAE in Treatment of Fibroids Phase 4
Completed NCT03444987 - The Role of Fibroblast Activation in Uterine Fibroid
Active, not recruiting NCT06244251 - Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids N/A
Not yet recruiting NCT06153667 - Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)
Not yet recruiting NCT03450421 - Safety and Efficacy of Actamaxâ„¢Adhesion Barrier in Women Undergoing Laparoscopic Abdominopelvic Surgery/Myomectomy N/A
Not yet recruiting NCT05840042 - Epidemiology and Risk Factors of Uterine Fibroids in China
Completed NCT04345003 - MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids N/A
Recruiting NCT03118037 - Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry